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Is the page turned tor radiotherapy in a
combined approach with surgery? In view ot the
available randomized triais and the recent
metaanalysis, a quick answer is yes. Indeed,
both observed either no effect ar even a
detrimental impact on survival. Nevertheless,
those triais were performed during the last three
decades, a period ot many improvements in the
knowledge ot the disease, in imaging procedure,
in surgery and in radiotherapy. Preoperative
radiotherapy may increase the resectability rate
in well-selected patienł: same groups are still
advocating this approach tor superior sulcus
tumor whereas many phase II and same phase
III triais are combining radiation with
chemotherapy in a preoperative settings. The
data available suggested a higher rate ot
pathological complete response but also a slight
increase in morbidity. In contrast, postoperative
irradiation improves the local control especially
tor stage III disease: this was clearly
demonstrated by the Lung Cancer Study group
trial, the MRC trial and the Feng tria!.
Furthermore, we should remember that the
PORT metaanalysis suggested a differential
impact according to the tumor extenł: the
negative impact ot postoperative radiation
disappeared tor stage III disease (a similar
observation was made by Oautzenberg et al).
One possible explanation is that the therapeutic
effect ot postoperative radiotherapy
compensated the negative impact due to a poor
radiation technique (Iarge volume, high daily
dose, and cobalt machines...). Both approaches
imply to use a modern radiation technique
minimizing the risk ot inducing severe lite-
threatening late ettects: this is especially the
case for postoperative radiotherapy due to the
already loss ot lung tunction due to the surgery
and a long history ot tobacco abuse. This is
probably the place for aconformal
radiotherapeutic approach.
The last issue concerns the management of
patients after induction chemotherapy fol/owed
by surgery: the current approach is to reserve
postoperative radiotherapy for incomplete
resection or tor persistent nodal disease.
Probably, another important tactor may be the
presence ar not of nodal capsular rupture. We
are certainly lacking good data on the
postresection management and outcome of
those patients.
In conclusion, radiation has stil! its place tor
stage III disease in a combined approach with
surgery and chemotherapy providing the use ot
an adequate radiation technique.
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The data from over 3000 breast cancer
patients treated without adjuvant chemotherapy
and fol/owed-up for over 15 years were studied
with two aims:
1) to analyze the relationship between tumor
diameter and incidence ot distant
metastases during the 25 years after initial
treatment. The threshold volume at which
dissemination occurs can be estimated in
each subset ot patients and varies widely; it
is inversely correlated with the histologie
grade and the number of involved axil/ary
nodes.
2) to investigate the impact ot a residual tumor
on distant dissemination. In patients with
local recurrence, the incidence ot distant
dissemination is elevated. The analysis ot
the delay between the initial treatment and
clinical emergence of the metastases shows
that the excess ot metastases corresponds
to disseminations which are initiated after
initial treatment and theretore originated
from the residual tumor.
This conclusion was supported by the update
of s control/ed clinical trial comparing two
adjuvant treatments: A) a chemotherapy by
CMF or B) post-operative radiotherapy (RT)
tollowed by immunothcrapy with poły A - poly U.
At 15 years the cumulative incidence ot local
recurrence and of distant metastases is
significantly lower in the B group (42%
metastasis-tree survival in the RT group and
29% in the CT group p=0.03). This result seems
to be due mostly to lower incidence of local
recurrence.
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